Regulation of collagen gene expression by prostaglandins and interleukin-1β in cultured chondrocytes and fibroblasts

American Journal of Therapeutics

Volumn 3, Issue 1, 1996, Pages 9-16

  Goldring, Mary B ^a,b   Suen, Lii Fang ^a,b   Yamin, Rina ^a,b   Lai, Wen Fu Thomas ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cartilage; Cytokines; Extracellular matrix; Fibrosis; Indomethacin

Indexed keywords

COLLAGEN TYPE 1; INDOMETACIN; INTERLEUKIN 1BETA; MISOPROSTOL; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARTILAGE CELL; CARTILAGE MATRIX; COLLAGEN SYNTHESIS; DRUG EFFECT; FIBROBLAST; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; REGENERATION;

EID: 0030030808     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-199601000-00003     Document Type: Article

References (64)

1. Goldring MB: Degradation of articular cartilage in culture: regulatory factors. In: Joint Cartilage Degradation: Basic and Clinical Aspects (Eds. Woessner, JF Jr, Howell, DS), Marcel Dekker, New York, 1992, pp. 281-345.
2. Krane SM, Conca W, Stephenson ML, Amento EP, Goldring MB: Mechanisms of matrix degradation in rheumatoid arthritis. Ann NY Acad Sci 1990;580:340-354.
3. Hamerman D: The biology of osteoarthritis. N Engl J Med 1989;320:1322-1330.
4. Harris ED JR: Rheumatoid arthritis: pathophysiology and implications for therapy. N Engl J Med 1990;322:1277-1289.
5. 2 production by human synovial cells. J Clin Invest 1986;77:645-648.
6. McCroskery PA, Arai S, Amento EP, Krane SM: Stimulation of procollagenase synthesis in human rheumatoid synovial fibroblasts by mononuclear cell factor/interleukin 1. FEBS Lett 1985;191:7-12.
7. McGuire-Goldring MB, Meats JE, Wood DD, Ihrie EJ, Ebsworth NM, Russell RGG: In vitro activation of human chondrocytes and synoviocytes by a human interleukin-1-like factor. Arthritis Rheum 1984;27:654-662.
8. Meats JE, McGuire MKB, Ebsworth NM, Englis DJ, Russell RGG: Enhanced production of prostaglandins and plasminogen activator during activation of human articular chondrocytes by products of mononuclear cells. Rheumatol Int 1984;4:143-149.
9. Stephenson ML, Goldring MB, Birkhead JR, Krane SM, Rahmsdorf HJ, Angel P: Stimulation of procollagenase synthesis parallels increases in cellular procollagenase mRNA in human articular chondrocytes exposed to recombinant interleukin 1β or phorbol ester. Biochem Biophys Res Commun 1987;144:583-590.
10. Wood DD, Bayne EK, Goldring MB, Gowen M, Hamerman D, Humes JL, Ihrie EJ, Lipsky PE, Staruch M-J: The four biochemically distinct species of human interleukin 1 all exhibit similar biologic activities. J Immunol 1985;134: 895-903.
11. Dodge GR, Poole AR: Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in explants of bovine articular cartilages and in explants of bovine articular cartilage cultured with interleukin 1. J Clin Invest 1989;83:647-661.
12. Goldring MB, Birkhead J, Sandell LJ, Kimura T, Krane SM: Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes. J Clin Invest 1988;82:2026-2037.
13. Tyler JA, Benton HP: Synthesis of type II collagen is decreased in cartilage cultured with interleukin 1 while the rate of intracellular degradation remains unchanged. Coll Relat Res 1988;8:393-405.
14. Yaron I, Meyer FA, Dayer J-M, Bleiberg I, Yaron M: Some recombinant human cytokines stimulate glycosaminoglycan synthesis in human synovial fibroblast cultures and inhibit it in human articular cartilage cultures. Arthritis Rheum 1989;32:173-180.
15. Tyler JA: Articular cartilage cultured with catabolin (pig interleukin 1) synthesizes a decreased number of normal proteoglycan molecules. Biochem J 1985;227:869-878.
16. Ikebe T, Hirata M, Koga T: Effects of human recombinant tumor necrosis factor-α and interleukin 1 on the synthesis of glycosaminoglycan and DNA in cultured rat costal chondrocytes. J Immunol 1988;140:827-831.
17. Goldring MB, Krane SM: Modulation by recombinant interleukin 1 of synthesis of types I and III collagens and associated procollagen mRNA levels in cultured human cells. J Biol Chem 1987;262:16724-16729.
18. 2 and indomethacin. Coll Relat Res 1985;5:99-117.
19. 2 causes a coordinate decrease in the steady state levels of fibronectin and type I and III procollagen mRNAs in normal human dermal fibroblasts. Biochem Biophys Res Commun 1987;147:1282-1288.
20. 1 on collagen production and degradation in human fetal lung fibroblasts. Arch Biochem Biophys 1988;265:441-446.
21. Goldring MB, Sohbat E, Elwell JM, Chang JY: Etodolac preserves cartilage-specific phenotype in human chondrocytes: Effects on type II collagen synthesis and associated mRNA levels. Eur J Rheumatol Inflamm 1990;10:10-21.
22. Brandt KD: Effects of nonsteroidal anti-inflammatory drugs on chondrocyte metabolism in vitro and in vivo. Am J Med 1987;83:29-84.
23. Pettipher ER, Henderson B, Edwards JCW, Higgs GA: Effect of indomethacin on swelling, lymphocyte influx, and cartilage proteoglycan depletion in experimental arthritis. Ann Rheum Dis 1989;48:623-627.
24. Dingle JT, Shield MJ: The interactions of cytokines, NSAIDs and prostaglandins in cartilage destruction and repair. In: Advances in Prostaglandin, Thromboxane, and Leukotriene Research Vol. 21B (Eds. Samuelson B, Ramwell PW, Paoletti R, Folco G, Granstrom E), Raven Press, New York, 1990, pp. 955-966.
25. Dingle JT: Prostaglandins in human cartilage metabolism. J Lipid Mediat 1993;6:303-312.
26. Ghosh P, Wells C, Smith M, Hutadilok N: Chondroprotection, myth or reality: an experimental approach. Semin Arthritis Rheum 1990;19(Suppl 1):3-9.
27. Vignon E, Mathieu P, Broquet P, Louisot P, Richard M: Cartilage degradative enzymes in human osteoarthritis: effect of a nonsteroidal antiinflammatory drug administered orally. Semin Arthritis Rheum 1990;19(Suppl 1):26-29.
28. Abramson SB, Weissmann G: The mechanisms of action of nonsteroidal anti-inflammatory drugs. Arthritis Rheum 1989;32:1-9.
29. Zurier RB: Role of prostaglandins E in inflammation and immune responses. In: Advances in Prostaglandin, Thromboxane, and Leukotriene Research Vol. 21B (Eds. Samuelson B, Ramwell PW, Paoletti R, Folco G, Granstrom E), Raven Press, New York, 1990, pp. 947-953.
30. Goldring MB, Fukuo K, Birkhead JR, Dudek E, Sandell LJ: Transcriptional suppression by interleukin-1 and interferon-γ of type II collagen gene expression in human chondrocytes. J Cell Biochem 1994;54:85-99.
31. Goldring MB, Birkhead JR, Suen L-F, Yamin R, Mizuno S, Glowacki J, Arbiser J, Apperley JF: Interleukin-1β-modulated gene expression in immortalized human chondrocytes. J Clin Invest 1994;94:2307-2316.
32. Karsenty G, deCrombrugghe B: Two different negative and one positive regulatory factors interact with a short promoter segment of the α1(I) collagen gene. J Biol Chem 1990;265:9934-9942.
33. Neumann CA, Morency CA, Russian KO: A novel rapid assay for chloramphenicol acetyltransferase gene expression. Biotechniques 1987;5:444-448.
34. O'Keefe RJ, Crabb ID, Puzas JE, Rosier RN: Influence of prostaglandins on DNA and matrix synthesis in growth plate chondrocytes. J Bone Miner Res 1992;7:397-404.
35. Mauviel A, Kahari V-M, Heino J, Daireaux M, Hartmann DJ, Loyau G, Pujol J-P: Gene expression of fibroblast matrix proteins is altered by indomethacin. FEBS Lett 1988;231:125-129.
36. 2 inhibits α1(I)procollagen gene transcription and promoter activity in the immortalized rat osteoblastic clonal cell line Py1a. Mol Endocrinol 1993;7: 17-22.
37. 2. J Biol Chem 1993;268:10364-10371.
38. Jones IL, McGuire MB, Klamfeldt A: Enhanced breakdown of bovine articular cartilage proteoglycans by conditioned synovial medium in vitro: a possible role for prostaglandins. Scand J Rheumatol 1982;11:177-183.
39. Houston JP, McGuire MKB, Meats JE, Ebsworth NM, Russell RGG, Crawford A, MacNeil S: Adenylate cyclase of human articular chondrocytes. Responsiveness to prostaglandins and other hormones. Biochem J 1982;208: 35-42.
40. Baker DG, Dayer J-M, Roelke M, Schumacher HR, Krane SM: Rheumatoid synovial cell morphologic changes induced by a mononuclear cell factor in culture. Arthritis Rheum 1982;26:8-14.
41. Goldring SR, Dayer J-M, Krane SM: Rheumatoid synovial cell hormone responses modulated by cell-cell interactions. Inflammation 1984;8:107-121.
42. 2 on bone formation in cultured fetal rat calvariae: interaction with cortisol. Endocrinology 1990;126:1654-1659.
43. 2α is a potent inhibitor of collagen synthesis in rat osteoblastic Py1a cells. J Bone Miner Res 1992;8:S224.
44. Centrella M, Canalis E, McCarthy TL: Differential actions of prostaglandins (PGs) in distinct cell populations from fetal rat bone. J Bone Miner Res 1991;7:S126.
45. 2 inhibits DNA and collagen synthesis in rat chondroblast-like RCJ 3.1C5 cells. J Bone Miner Res 1991;7:S211.
46. Kahari V-M, Heino J, Vuorio E: Interleukin-1 increases collagen production and mRNA levels in cultured skin fibroblasts. Biochim Biophys Acta 1987;929:142-147.
47. Postlethwaite AE, Raghow R, Stricklin GP, Poppleton H, Seyer JM, Kang AH: Modulation of fibroblast functions by interleukin 1: increased steady-state accumulation of type I procollagen messenger RNAs and stimulation of other functions but not chemotaxis by human recombinant interleukin 1a and b. J Cell Biol 1988;106:311-318.
48. Duncan MR, Berman B: Differential regulation of collagen, glycosaminoglycan, fibronectin, and collagenase activity production in cultured human adult dermal fibroblasts by interleukin 1-α and β and tumor necrosis factor-α and β. J Invest Dermatol 1989;92:699-706.
49. Elias JA, Freundlich B, Adams S, Rosenbloom J: Regulation of human lung fibroblast collagen production by recombinant interleukin-1, tumor necrosis factor, and interferon-γ. Ann NY Acad Sci 1990;580:233-244.
50. Harrison JR, Vargas SJ, Petersen DN, Lorenzo JA, Kream BE: Interleukin-1α and phorbol ester inhibit collagen synthesis in osteoblastic MC3T3-E1 cells by a transcriptional mechanism. Mol Endocrinol 1990;4:184-190.
51. Harrison JR, Lichtler AC, LaFrancis D, Rowe DW, Kream BE: Positive or negative regulation of α1(I) collagen promoter activity by interleukin-1α and tumor necrosis factor-α in MC3T3-E1 cells depends on cell maturation. J Bone Miner Res 1991;6:S83.
52. Mauviel A, Heino J, Kahari VM, Hartmann DJ, Loyau G, Pujol JP, Vuorio E: Comparative effects of interleukin-1 and tumor necrosis factor-α on collagen production and corresponding procollagen mRNA levels in human dermal fibroblasts. J Invest Dermatol 1991;96:243-249.
53. Armendariz-Borunda J, Katayama K, Seyer JM: Transcriptional mechanisms of type I collagen gene expression are differentially regulated by interleukin-1β, tumor necrosis factor α and transforming growth factor β in Ito cells. J Biol Chem 1992;267:14316-14321.
54. 2 and cyclic adenosine 3′,5′-monophosphate. Biochim Biophys Acta 1979;586:87.
55. 2, indomethacin, trifluoperazine and drugs affecting the cytoskeleton on collagenase production by cultured adherent rheumatoid synovial cells. Biochem Pharmacol 1984;33:2893-2899.
56. 1 inhibits collagenase gene expression in rabbit synoviocytes and human fibroblasts. Endocrinology 1992;131:21-28.
57. Baker DG, Krakauer KA, Tate G, Laposata M, Zurier RB: Suppression of human synovial cell proliferation by dihomo-γ-linoleic acid: Arthritis Rheum 1989;32:1273-1281.
58. Namba T, Sugimoto Y, Negishi MAI, Irie A, Ushikubi F, Kakizuka A, Ito S, Ichikawa A, Narumiya S: Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature 1993;365:166-170.
59. Muallem S, Merritt BS, Green J, Kleeman CR, Yamaguchi DT: Classification of prostaglandin receptors based on coupling to signal transduction systems. Biochem J 1989;263:769-774.
60. ++-regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science 1991;252:1427-1430.
61. Imagawa M, Chiu R, Karin M: Transcription factor AP-2 mediates induction by two different signal-transduction pathways: Protein kinase C and cAMP. Cell 1987;51:251-260.
62. Ivashkiv LB, Glimcher LH: Repression of class II major histocompatibility complex genes by cyclic AMP is mediated by conserved promoter elements. J Exp Med 1991; 174:1583-1592.
63. Shirakawa F, Chedid M, Suttles J, Pollok BA, Mizel SB: Interleukin 1 and cyclic AMP induce κ immunoglobulin light-chain expression via activation of an NF-κB-like DNA-binding protein. Mol Cell Biol 1989;9:959-964.
64. Jain J, McCaffrey PG, Miner Z, Kerppola TK, Lambert JN, Verdine GL, Curran T, Rao A: The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun. Nature 1993;365:352-355.